Compounds > 8-aminoadenosine
Page last updated: 2024-08-26

8-aminoadenosine and Kahler Disease

8-aminoadenosine has been researched along with Kahler Disease in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Avram, MJ; Gandhi, V; Krett, NL; McBrayer, SK; Qian, J; Raikoff, K; Rosen, ST; Schumacker, PT; Shanmugam, M; Singhal, S1
Eitaki, M; Inanami, O; Matsuda, A; Meike, S; Yamamori, T; Yasui, H1
Feng, G; Gandhi, V; Krett, NL; McBrayer, SK; Qian, J; Rosen, ST; Shanmugam, M; Yarrington, M1
Ayres, M; Davies, KM; Gandhi, V; Krett, NL; Ma, C; Nabhan, C; Rosen, ST1
Gandhi, V; Ghias, K; Krett, NL; Ma, C; Platanias, LC; Rosen, ST1

Other Studies

5 other study(ies) available for 8-aminoadenosine and Kahler Disease

ArticleYear
Targeting glucose consumption and autophagy in myeloma with the novel nucleoside analogue 8-aminoadenosine.
    The Journal of biological chemistry, 2009, Sep-25, Volume: 284, Issue:39

    Topics: Adenosine; Adenosine Triphosphate; Autophagy; Cell Line, Tumor; Cell Membrane; Cell Proliferation; Chloroquine; Cytoplasm; Dose-Response Relationship, Drug; Drug Synergism; Glucose; Glucose Transporter Type 1; Glucose Transporter Type 4; Humans; Immunoblotting; Microscopy, Fluorescence; Multiple Myeloma; Time Factors; Tumor Cells, Cultured

2009
8-Aminoadenosine enhances radiation-induced cell death in human lung carcinoma A549 cells.
    Journal of radiation research, 2011, Volume: 52, Issue:4

    Topics: Adenocarcinoma; Adenosine; Adenosine Triphosphate; Apoptosis; Caspase Inhibitors; Cell Death; Cell Line, Tumor; Dose-Response Relationship, Radiation; Humans; Microscopy, Fluorescence; Multiple Myeloma; Peptides; Propidium; Radiation-Sensitizing Agents; Signal Transduction; X-Rays

2011
Integrative gene expression profiling reveals G6PD-mediated resistance to RNA-directed nucleoside analogues in B-cell neoplasms.
    PloS one, 2012, Volume: 7, Issue:7

    Topics: 2-Chloroadenosine; Adenosine; Cell Line, Tumor; Clinical Trials, Phase I as Topic; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Gene Expression Profiling; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Glucosephosphate Dehydrogenase; Hematologic Neoplasms; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Mantle-Cell; Multiple Myeloma; Neoplasm Proteins; Pentose Phosphate Pathway; RNA, Neoplasm

2012
8-amino-adenosine is a potential therapeutic agent for multiple myeloma.
    Molecular cancer therapeutics, 2004, Volume: 3, Issue:11

    Topics: Adenosine; Apoptosis; Caspases; Cell Line, Tumor; DNA; Dose-Response Relationship, Drug; Enzyme Activation; Humans; Molecular Structure; Multiple Myeloma; Phosphorylation; Polyphosphates; RNA

2004
8-Amino-adenosine induces loss of phosphorylation of p38 mitogen-activated protein kinase, extracellular signal-regulated kinase 1/2, and Akt kinase: role in induction of apoptosis in multiple myeloma.
    Molecular cancer therapeutics, 2005, Volume: 4, Issue:4

    Topics: Adenosine; Adenosine Triphosphate; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Flow Cytometry; Humans; Immunoblotting; JNK Mitogen-Activated Protein Kinases; Kinetics; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Multiple Myeloma; Nucleosides; p38 Mitogen-Activated Protein Kinases; Phosphoric Monoester Hydrolases; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Purines; Signal Transduction; Time Factors

2005